Nexien BioPharma, Inc. (OTCMKTS:NXEN) Short Interest Update

Nexien BioPharma, Inc. (OTCMKTS:NXEN) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 28,900 shares, an increase of 28,800.0% from the March 31st total of 100 shares. Based on an average daily volume of 22,100 shares, the days-to-cover ratio is currently 1.3 days.

Nexien BioPharma Price Performance

OTCMKTS:NXEN opened at $0.02 on Friday. The business’s 50 day moving average is $0.02 and its two-hundred day moving average is $0.02. Nexien BioPharma has a 52 week low of $0.01 and a 52 week high of $0.10. The company has a market cap of $1.13 million, a PE ratio of -1.68 and a beta of 1.60.

Nexien BioPharma Company Profile

Nexien BioPharma, Inc focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company was formerly known as Intiva BioPharma Inc and changed its name to Nexien BioPharma, Inc in September 2018.